CH Biotech R&D Co., Ltd. (TPE:6534)

CH Biotech R&D Revenue

CH Biotech R&D had revenue of 869.50M TWD in the quarter ending March 31, 2026, with 1.86% growth. This brings the company's revenue in the last twelve months to 1.84B, up 10.24% year-over-year. In the year 2025, CH Biotech R&D had annual revenue of 1.82B with 11.21% growth.

• Revenue (ttm): 1.84B
• Revenue Growth: +10.24%
• P/S Ratio: 5.11
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 9.39B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.82B	183.45M	11.21%
Dec 31, 2024	1.64B	120.91M	7.98%
Dec 31, 2023	1.51B	80.71M	5.63%
Dec 31, 2022	1.43B	415.61M	40.81%
Dec 31, 2021	1.02B	316.32M	45.05%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error